Last reviewed · How we verify
Intravenous moderate sedation versus oral medication
At a glance
| Generic name | Intravenous moderate sedation versus oral medication |
|---|---|
| Sponsor | University of California, San Francisco |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke (PHASE4)
- Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders (NA)
- Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia (PHASE4)
- Comparing the Effectiveness of Oral Versus Intravenous Pain Medicine for Suction Curettage (D&C) (NA)
- Trial Comparing Intravenous and Oral Moderate Sedation for First Trimester Surgical Abortions (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: